Shilpa Bhupathiraju, Ph.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Diet | 43 | 2024 | 7939 | 2.720 |
Why?
|
Diabetes Mellitus, Type 2 | 31 | 2024 | 11725 | 2.130 |
Why?
|
Diet, Mediterranean | 8 | 2023 | 700 | 1.460 |
Why?
|
Eggs | 2 | 2020 | 184 | 1.330 |
Why?
|
Feeding Behavior | 12 | 2021 | 3188 | 1.250 |
Why?
|
Nurses | 11 | 2021 | 2461 | 1.230 |
Why?
|
Cardiovascular Diseases | 23 | 2024 | 15165 | 1.230 |
Why?
|
Diet, Vegetarian | 6 | 2022 | 174 | 1.200 |
Why?
|
Menopause | 4 | 2018 | 1626 | 1.160 |
Why?
|
Estrogens, Conjugated (USP) | 2 | 2018 | 275 | 1.140 |
Why?
|
Fruit | 10 | 2021 | 1142 | 1.130 |
Why?
|
Vegetables | 9 | 2024 | 1182 | 1.110 |
Why?
|
Metabolomics | 8 | 2024 | 1484 | 1.060 |
Why?
|
Life Style | 11 | 2022 | 3835 | 0.990 |
Why?
|
Methylamines | 1 | 2024 | 123 | 0.900 |
Why?
|
Nutritional Status | 9 | 2024 | 1609 | 0.880 |
Why?
|
Hyperinsulinism | 2 | 2022 | 415 | 0.840 |
Why?
|
Nuts | 3 | 2021 | 257 | 0.840 |
Why?
|
Coffee | 7 | 2022 | 578 | 0.830 |
Why?
|
Nutritive Value | 5 | 2021 | 339 | 0.810 |
Why?
|
Atherosclerosis | 3 | 2023 | 3445 | 0.750 |
Why?
|
Dietary Carbohydrates | 4 | 2020 | 906 | 0.720 |
Why?
|
Proteomics | 2 | 2023 | 3638 | 0.690 |
Why?
|
Postmenopause | 7 | 2024 | 2461 | 0.680 |
Why?
|
Estrogen Replacement Therapy | 3 | 2022 | 1203 | 0.610 |
Why?
|
Specimen Handling | 1 | 2022 | 694 | 0.600 |
Why?
|
Medroxyprogesterone Acetate | 1 | 2017 | 162 | 0.580 |
Why?
|
Follow-Up Studies | 30 | 2024 | 39050 | 0.570 |
Why?
|
Coronary Disease | 7 | 2022 | 6077 | 0.560 |
Why?
|
Nutrition Assessment | 7 | 2021 | 723 | 0.550 |
Why?
|
Dietary Proteins | 3 | 2021 | 963 | 0.550 |
Why?
|
Puerto Rico | 9 | 2020 | 356 | 0.530 |
Why?
|
Hip Fractures | 1 | 2024 | 955 | 0.530 |
Why?
|
Dietary Fats | 3 | 2021 | 2017 | 0.520 |
Why?
|
Cross-Sectional Studies | 20 | 2024 | 25043 | 0.500 |
Why?
|
Risk Factors | 46 | 2023 | 72290 | 0.500 |
Why?
|
Anthropometry | 5 | 2021 | 1350 | 0.500 |
Why?
|
Hot Flashes | 1 | 2017 | 317 | 0.500 |
Why?
|
Prospective Studies | 37 | 2024 | 53288 | 0.480 |
Why?
|
Hormone Replacement Therapy | 2 | 2017 | 745 | 0.480 |
Why?
|
Beverages | 5 | 2024 | 820 | 0.470 |
Why?
|
Contraceptives, Oral | 1 | 2016 | 564 | 0.470 |
Why?
|
Drinking Behavior | 1 | 2014 | 103 | 0.460 |
Why?
|
Obesity | 11 | 2023 | 12745 | 0.460 |
Why?
|
Energy Intake | 7 | 2021 | 2148 | 0.440 |
Why?
|
Glycemic Index | 2 | 2017 | 395 | 0.430 |
Why?
|
Abdominal Fat | 2 | 2011 | 223 | 0.420 |
Why?
|
Humans | 106 | 2024 | 744343 | 0.420 |
Why?
|
Body Mass Index | 10 | 2018 | 12720 | 0.410 |
Why?
|
Bone Density | 4 | 2013 | 3468 | 0.410 |
Why?
|
Forecasting | 2 | 2017 | 2951 | 0.400 |
Why?
|
Caffeine | 2 | 2014 | 699 | 0.400 |
Why?
|
Metabolic Diseases | 1 | 2018 | 658 | 0.400 |
Why?
|
Obesity, Abdominal | 3 | 2021 | 361 | 0.390 |
Why?
|
Middle Aged | 58 | 2024 | 213383 | 0.390 |
Why?
|
United States | 31 | 2024 | 69872 | 0.390 |
Why?
|
Diabetes Mellitus | 3 | 2020 | 5751 | 0.380 |
Why?
|
Cause of Death | 7 | 2023 | 3584 | 0.380 |
Why?
|
Overweight | 3 | 2018 | 2371 | 0.370 |
Why?
|
Female | 68 | 2024 | 380194 | 0.360 |
Why?
|
Bone and Bones | 2 | 2013 | 2575 | 0.360 |
Why?
|
Cohort Studies | 18 | 2024 | 40561 | 0.350 |
Why?
|
Pesticide Residues | 2 | 2021 | 95 | 0.350 |
Why?
|
Diet Surveys | 4 | 2021 | 1173 | 0.340 |
Why?
|
Patient Compliance | 4 | 2015 | 2684 | 0.340 |
Why?
|
Longitudinal Studies | 9 | 2024 | 13989 | 0.330 |
Why?
|
Diabetes Complications | 1 | 2016 | 1359 | 0.330 |
Why?
|
Eating | 4 | 2023 | 1536 | 0.330 |
Why?
|
Malnutrition | 4 | 2021 | 625 | 0.320 |
Why?
|
Bone Resorption | 1 | 2011 | 723 | 0.300 |
Why?
|
Folic Acid | 3 | 2023 | 1300 | 0.300 |
Why?
|
Sweetening Agents | 4 | 2024 | 296 | 0.290 |
Why?
|
Micronutrients | 4 | 2021 | 375 | 0.280 |
Why?
|
Epidemiologic Studies | 2 | 2022 | 676 | 0.270 |
Why?
|
Adult | 40 | 2024 | 214055 | 0.270 |
Why?
|
Chronic Disease | 2 | 2018 | 9146 | 0.270 |
Why?
|
Incidence | 12 | 2023 | 20947 | 0.260 |
Why?
|
Carnitine | 2 | 2024 | 246 | 0.260 |
Why?
|
India | 3 | 2021 | 2197 | 0.260 |
Why?
|
Risk | 8 | 2021 | 9687 | 0.260 |
Why?
|
Aged | 35 | 2022 | 163280 | 0.250 |
Why?
|
Meglutol | 1 | 2024 | 5 | 0.250 |
Why?
|
Proportional Hazards Models | 10 | 2020 | 12354 | 0.240 |
Why?
|
Male | 46 | 2024 | 350118 | 0.240 |
Why?
|
Osteoporosis, Postmenopausal | 1 | 2007 | 386 | 0.240 |
Why?
|
Betaine | 1 | 2024 | 87 | 0.240 |
Why?
|
Homocysteine | 1 | 2007 | 647 | 0.240 |
Why?
|
Soy Foods | 1 | 2024 | 48 | 0.240 |
Why?
|
American Heart Association | 3 | 2013 | 1056 | 0.230 |
Why?
|
Blood Glucose | 4 | 2021 | 6256 | 0.230 |
Why?
|
Nutrition Surveys | 5 | 2024 | 1660 | 0.230 |
Why?
|
Riboflavin | 1 | 2023 | 108 | 0.220 |
Why?
|
C-Reactive Protein | 6 | 2016 | 3778 | 0.220 |
Why?
|
Boston | 9 | 2024 | 9313 | 0.220 |
Why?
|
Diabetes, Gestational | 2 | 2022 | 1184 | 0.210 |
Why?
|
Smoking | 2 | 2018 | 8987 | 0.210 |
Why?
|
Choline | 1 | 2024 | 493 | 0.210 |
Why?
|
Mortality | 3 | 2020 | 2864 | 0.210 |
Why?
|
Overnutrition | 1 | 2021 | 26 | 0.200 |
Why?
|
Hemoglobins | 3 | 2021 | 1534 | 0.200 |
Why?
|
Plants | 2 | 2021 | 316 | 0.200 |
Why?
|
Dietary Fiber | 3 | 2017 | 760 | 0.200 |
Why?
|
Risk Assessment | 4 | 2020 | 23338 | 0.200 |
Why?
|
Waist Circumference | 3 | 2021 | 917 | 0.200 |
Why?
|
Asia | 2 | 2020 | 610 | 0.200 |
Why?
|
Glucose | 2 | 2024 | 4397 | 0.190 |
Why?
|
Inflammation Mediators | 3 | 2020 | 1889 | 0.190 |
Why?
|
Juglans | 1 | 2021 | 43 | 0.190 |
Why?
|
Diet Therapy | 1 | 2021 | 154 | 0.180 |
Why?
|
Adiposity | 3 | 2023 | 1807 | 0.170 |
Why?
|
Rural Population | 4 | 2021 | 2210 | 0.170 |
Why?
|
Food | 2 | 2021 | 771 | 0.170 |
Why?
|
Administration, Intravaginal | 1 | 2018 | 150 | 0.160 |
Why?
|
Stroke | 3 | 2022 | 9981 | 0.160 |
Why?
|
Health Status | 2 | 2021 | 4034 | 0.160 |
Why?
|
Food Contamination | 1 | 2019 | 188 | 0.160 |
Why?
|
Reproducibility of Results | 3 | 2023 | 19905 | 0.160 |
Why?
|
Inflammation | 4 | 2020 | 10638 | 0.150 |
Why?
|
Myocardial Infarction | 1 | 2018 | 11727 | 0.150 |
Why?
|
Guidelines as Topic | 3 | 2013 | 1405 | 0.150 |
Why?
|
Women's Health | 2 | 2017 | 2034 | 0.150 |
Why?
|
Food Preferences | 1 | 2020 | 399 | 0.140 |
Why?
|
Risk Reduction Behavior | 2 | 2021 | 1125 | 0.140 |
Why?
|
Communicable Disease Control | 1 | 2023 | 857 | 0.140 |
Why?
|
Adiponectin | 1 | 2022 | 1100 | 0.140 |
Why?
|
Allostasis | 2 | 2015 | 70 | 0.140 |
Why?
|
Europe | 2 | 2020 | 3339 | 0.140 |
Why?
|
Prediabetic State | 1 | 2021 | 499 | 0.140 |
Why?
|
Cholesterol, LDL | 2 | 2022 | 2356 | 0.140 |
Why?
|
State Medicine | 1 | 2017 | 217 | 0.140 |
Why?
|
Multivariate Analysis | 4 | 2018 | 12245 | 0.130 |
Why?
|
Starch | 1 | 2015 | 81 | 0.130 |
Why?
|
Mexican Americans | 1 | 2016 | 166 | 0.130 |
Why?
|
Mexico | 3 | 2021 | 690 | 0.130 |
Why?
|
Body Weight | 3 | 2021 | 4669 | 0.120 |
Why?
|
Magnesium | 1 | 2017 | 813 | 0.120 |
Why?
|
Citrus | 1 | 2013 | 41 | 0.120 |
Why?
|
Neurodegenerative Diseases | 1 | 2023 | 1061 | 0.120 |
Why?
|
Leptin | 1 | 2021 | 1599 | 0.110 |
Why?
|
Young Adult | 9 | 2021 | 56430 | 0.110 |
Why?
|
Dietary Sucrose | 1 | 2015 | 246 | 0.110 |
Why?
|
Ferritins | 3 | 2021 | 590 | 0.110 |
Why?
|
Neoplasms | 2 | 2019 | 21683 | 0.110 |
Why?
|
Plant Leaves | 1 | 2013 | 143 | 0.110 |
Why?
|
Dietary Supplements | 2 | 2023 | 3297 | 0.110 |
Why?
|
Osteoporosis | 2 | 2013 | 1580 | 0.110 |
Why?
|
Energy Metabolism | 2 | 2021 | 2899 | 0.110 |
Why?
|
Primary Prevention | 1 | 2020 | 1167 | 0.110 |
Why?
|
Vitamin D Deficiency | 1 | 2022 | 1343 | 0.110 |
Why?
|
Autonomic Nervous System | 1 | 2017 | 671 | 0.110 |
Why?
|
Comparative Effectiveness Research | 1 | 2017 | 681 | 0.100 |
Why?
|
Health Surveys | 2 | 2020 | 4037 | 0.100 |
Why?
|
beta Carotene | 1 | 2013 | 527 | 0.100 |
Why?
|
Anemia | 1 | 2021 | 1506 | 0.100 |
Why?
|
Carbonated Beverages | 1 | 2012 | 214 | 0.100 |
Why?
|
Weight Gain | 1 | 2021 | 2292 | 0.100 |
Why?
|
Self Report | 3 | 2020 | 3558 | 0.100 |
Why?
|
Tea | 1 | 2012 | 275 | 0.100 |
Why?
|
Socioeconomic Factors | 4 | 2021 | 7785 | 0.100 |
Why?
|
Health Personnel | 2 | 2015 | 3218 | 0.100 |
Why?
|
Ascorbic Acid | 1 | 2013 | 651 | 0.090 |
Why?
|
Diet Records | 2 | 2021 | 425 | 0.090 |
Why?
|
C-Peptide | 2 | 2022 | 419 | 0.090 |
Why?
|
Artificial Intelligence | 1 | 2023 | 2214 | 0.090 |
Why?
|
Adipose Tissue | 1 | 2021 | 3279 | 0.090 |
Why?
|
Acculturation | 1 | 2011 | 182 | 0.090 |
Why?
|
Time Factors | 4 | 2020 | 40075 | 0.090 |
Why?
|
Venous Thromboembolism | 1 | 2022 | 1671 | 0.090 |
Why?
|
Models, Statistical | 2 | 2021 | 5102 | 0.080 |
Why?
|
Arm | 2 | 2021 | 589 | 0.080 |
Why?
|
Iron | 1 | 2016 | 1774 | 0.080 |
Why?
|
Motor Activity | 3 | 2015 | 2714 | 0.080 |
Why?
|
Adolescent | 8 | 2021 | 85781 | 0.080 |
Why?
|
Bone Diseases, Metabolic | 1 | 2011 | 417 | 0.070 |
Why?
|
Absorptiometry, Photon | 1 | 2013 | 1725 | 0.070 |
Why?
|
Software | 1 | 2021 | 4443 | 0.070 |
Why?
|
Acute-Phase Proteins | 1 | 2008 | 262 | 0.070 |
Why?
|
Sleep | 3 | 2022 | 4623 | 0.070 |
Why?
|
Lumbar Vertebrae | 2 | 2013 | 1848 | 0.070 |
Why?
|
North America | 2 | 2023 | 1249 | 0.070 |
Why?
|
Health Behavior | 2 | 2015 | 2636 | 0.070 |
Why?
|
Survival Analysis | 1 | 2019 | 10252 | 0.070 |
Why?
|
Public Health | 1 | 2019 | 2603 | 0.070 |
Why?
|
Alcohol Drinking | 1 | 2019 | 3966 | 0.070 |
Why?
|
Mental Recall | 2 | 2021 | 1205 | 0.060 |
Why?
|
Massachusetts | 1 | 2017 | 8663 | 0.060 |
Why?
|
Regression Analysis | 2 | 2019 | 6459 | 0.060 |
Why?
|
Indonesia | 1 | 2024 | 119 | 0.060 |
Why?
|
China | 2 | 2021 | 2248 | 0.060 |
Why?
|
Sex Factors | 2 | 2020 | 10397 | 0.050 |
Why?
|
Placebos | 1 | 2007 | 1676 | 0.050 |
Why?
|
Pandemics | 1 | 2022 | 8388 | 0.050 |
Why?
|
Age Factors | 1 | 2019 | 18370 | 0.050 |
Why?
|
Cognition | 1 | 2020 | 6770 | 0.050 |
Why?
|
Logistic Models | 2 | 2013 | 13408 | 0.050 |
Why?
|
Carbohydrates | 1 | 2024 | 394 | 0.050 |
Why?
|
Uric Acid | 1 | 2007 | 766 | 0.050 |
Why?
|
Glutamates | 1 | 2021 | 398 | 0.050 |
Why?
|
Ethiopia | 1 | 2021 | 495 | 0.040 |
Why?
|
Hypothalamic Diseases | 1 | 2020 | 135 | 0.040 |
Why?
|
Africa South of the Sahara | 1 | 2021 | 724 | 0.040 |
Why?
|
Health Promotion | 1 | 2011 | 2205 | 0.040 |
Why?
|
Genetic Predisposition to Disease | 1 | 2020 | 17446 | 0.040 |
Why?
|
Acyltransferases | 1 | 2020 | 294 | 0.040 |
Why?
|
Lipoproteins, HDL | 1 | 2022 | 638 | 0.040 |
Why?
|
Autonomic Nervous System Diseases | 1 | 2020 | 257 | 0.040 |
Why?
|
Interleukin-6 | 3 | 2015 | 3200 | 0.040 |
Why?
|
Purines | 1 | 2021 | 594 | 0.040 |
Why?
|
Poultry | 1 | 2016 | 82 | 0.040 |
Why?
|
Animals | 3 | 2024 | 168757 | 0.030 |
Why?
|
Tumor Necrosis Factor-alpha | 3 | 2015 | 4420 | 0.030 |
Why?
|
New Zealand | 1 | 2016 | 355 | 0.030 |
Why?
|
Fasting | 1 | 2021 | 1593 | 0.030 |
Why?
|
Publication Bias | 1 | 2016 | 162 | 0.030 |
Why?
|
Receptors, Transferrin | 1 | 2016 | 296 | 0.030 |
Why?
|
Amino Acids | 1 | 2021 | 1736 | 0.030 |
Why?
|
Estrogens | 1 | 2022 | 1566 | 0.030 |
Why?
|
Linear Models | 2 | 2016 | 5952 | 0.030 |
Why?
|
Interleukin-1beta | 2 | 2010 | 972 | 0.030 |
Why?
|
Metabolome | 1 | 2020 | 895 | 0.030 |
Why?
|
Educational Status | 1 | 2021 | 2540 | 0.030 |
Why?
|
Sexual Behavior | 1 | 2023 | 2057 | 0.030 |
Why?
|
Vitamins | 1 | 2022 | 1622 | 0.030 |
Why?
|
Urban Population | 1 | 2021 | 2021 | 0.030 |
Why?
|
Cholesterol | 1 | 2022 | 2917 | 0.030 |
Why?
|
Double-Blind Method | 1 | 2007 | 12026 | 0.030 |
Why?
|
Exercise | 2 | 2023 | 5615 | 0.030 |
Why?
|
Aging | 1 | 2012 | 8664 | 0.030 |
Why?
|
Dyslipidemias | 1 | 2020 | 849 | 0.030 |
Why?
|
Australia | 1 | 2016 | 1170 | 0.030 |
Why?
|
Anemia, Iron-Deficiency | 1 | 2016 | 365 | 0.030 |
Why?
|
Income | 1 | 2021 | 1913 | 0.030 |
Why?
|
Data Collection | 1 | 2021 | 3341 | 0.030 |
Why?
|
Nutrition Policy | 1 | 2015 | 488 | 0.020 |
Why?
|
Research Design | 1 | 2007 | 5987 | 0.020 |
Why?
|
Breast Neoplasms | 1 | 2018 | 20822 | 0.020 |
Why?
|
Nonlinear Dynamics | 1 | 2013 | 502 | 0.020 |
Why?
|
Pregnancy | 2 | 2022 | 29144 | 0.020 |
Why?
|
Aged, 80 and over | 3 | 2021 | 57776 | 0.020 |
Why?
|
Prognosis | 2 | 2020 | 29063 | 0.020 |
Why?
|
Lipids | 1 | 2021 | 3305 | 0.020 |
Why?
|
Urban Health | 1 | 2012 | 547 | 0.020 |
Why?
|
Algorithms | 2 | 2021 | 13881 | 0.020 |
Why?
|
Vitamin D | 1 | 2022 | 3223 | 0.020 |
Why?
|
Cholesterol, HDL | 1 | 2013 | 1814 | 0.020 |
Why?
|
Neuropsychological Tests | 1 | 2020 | 6993 | 0.020 |
Why?
|
Insulin Resistance | 1 | 2020 | 3864 | 0.020 |
Why?
|
Swine | 1 | 2016 | 5917 | 0.020 |
Why?
|
Leukocyte Count | 1 | 2010 | 1588 | 0.020 |
Why?
|
Social Support | 1 | 2015 | 2118 | 0.020 |
Why?
|
Mass Screening | 1 | 2021 | 5255 | 0.020 |
Why?
|
Phenotype | 1 | 2023 | 16365 | 0.020 |
Why?
|
Statistics as Topic | 1 | 2012 | 2373 | 0.020 |
Why?
|
Fibrinogen | 1 | 2008 | 894 | 0.020 |
Why?
|
Case-Control Studies | 1 | 2021 | 21746 | 0.010 |
Why?
|
Femur | 1 | 2010 | 1297 | 0.010 |
Why?
|
Severity of Illness Index | 1 | 2021 | 15540 | 0.010 |
Why?
|
Dose-Response Relationship, Drug | 1 | 2014 | 10943 | 0.010 |
Why?
|
Genome-Wide Association Study | 1 | 2020 | 12261 | 0.010 |
Why?
|
Prevalence | 1 | 2016 | 15226 | 0.010 |
Why?
|
Disease Progression | 1 | 2014 | 13284 | 0.010 |
Why?
|
Hypertension | 1 | 2015 | 8480 | 0.010 |
Why?
|
Randomized Controlled Trials as Topic | 1 | 2008 | 9959 | 0.010 |
Why?
|
Heart Failure | 1 | 2013 | 10900 | 0.010 |
Why?
|
Treatment Outcome | 1 | 2013 | 63114 | 0.000 |
Why?
|